Perinatal management of spina bifida by Padayachy, Llewellyn & Ochieng’, Dan
CONTINUING MEDICAL EDUCATION
    March 2014, Vol. 104, No. 3
The management of patients with myelomeningocele (MMC) is 
largely dependent on the timing of the diagnosis, i.e. ante- or 
postnatally. As previously discussed in CME,[1] antenatal diagnosis can 
be made using a combination of maternal serum alpha-fetoprotein 
(MSAFP) measurement, fetal ultrasonography and, where necessary, 
amniocentesis. An elevated MSAFP should be repeated, and if both 
values are elevated, fetal ultrasound, which has a sensitivity of 90%, 
is recommended as the next step.[2] In the modern era, with routine 
antenatal screening, the majority of cases should be detected before 
delivery.
Adequate counselling of parents is incumbent on the treating 
doctor. The complexity of the diagnosis and its sequelae can be quite 
overwhelming for the family. It is therefore very important to discuss 
thoroughly the nature of the abnormality, as well as the possible 
consequences. The decision by the family to either continue with the 
pregnancy or to opt for termination of pregnancy, usually involves a 
complex mix of personal and religious factors, but may be strongly 
influenced by the advice of the treating doctor. With appropriate medical 
care, the majority of patients with this condition can enjoy a good quality 
of life. The current accepted mortality in patients with MMC is about 
25%, with 15% dying in the first 5 years of life.[3] When the decision 
to continue with the pregnancy has been made, the next step involves 
choosing the most appropriate manner of obstetric management.
Obstetric management
Once the diagnosis has been made antenatally, consideration should 
be given to the mode of delivery, i.e. vaginally or by caesarean section. 
Some clinicians recommend caesarean delivery before rupture of 
the amniotic membranes and the onset of labour in order to reduce 
injury and prevent infection of the MMC sac. However, long-term 
ambulation status in infants with MMC who underwent a trial 
of labour was no different than in those who underwent elective 
caesarean delivery.[4] Although parents who elect to continue with 
the pregnancy may prefer a planned caesarean section to optimise 
postnatal management, the decision as to mode of delivery should be 
made on the basis of accepted obstetric criteria.
Immediate postnatal care
The main priorities are protecting the open lesion to prevent 
infection and detecting brainstem dysfunction related to the 
Chiari II malformation, with a view to referring the newborn 
for surgical closure within 24 hours. Immediate assessment and 
management should include:
• ABCs, APGAR score, adequate resuscitation, noting stridor or any 
other brainstem signs
• evaluating the lesion with regard to
• size
• level
• content
• checking for associated congenital abnormalities (vertebral defects, 
anal atresia, cardiac defects, tracheo-oesophageal fistula, renal 
anomalies, and limb abnormalities (VACTERL syndrome)).
The lesion should be covered with a warm saline-soaked dressing to 
protect the placode and prevent desiccation. Although all MMCs are open 
lesions, and the most effective antimicrobial treatment is early surgical 
closure, some authors believe that an MMC that leaks cerebrospinal fluid 
(CSF) should be considered ‘ruptured’ and has a higher risk of infection. 
Because of the latter, they recommend the administration of antibiotics, 
preferably with Gram-negative and anaerobic cover, e.g. ceftriaxone and 
gentamicin. As thermoregulation is a major challenge, the infant should 
be nursed prone in an incubator. The infant usually commences breast-
feeding, but a nasogastric tube may be required if there is evidence of 
swallowing dysfunction or aspiration. As latex allergy is a long-term 
problem, all latex products must be avoided from the outset. Further 
investigations may include a swab for culture of the open lesion as well as 
blood for determining the  international normalised ratio (INR), full blood 
count (FBC) and cumulative urinary excretion (CUE). 
Once the neonate is stable, further neurological assessment must 
be done:
• measurement of the head circumference and assessment of the 
anterior fontanelle to check for hydrocephalus
• ascertaining the highest level of motor function by observing 
spontaneous movement of the lower limbs (Tables 1 and 2)
• assessment of anal tone by evaluating the muscle bulk of the 
buttocks and whether the anus is patulous 
• looking for signs related to Chiari II malformation, e.g. apnoea, 
stridor and swallowing difficulties.
Referral for neurosurgical closure should take place within 24 hours, 
or at most 48 hours. If delayed, there is a much greater likelihood that 
the lesion will be colonised and infected.
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Surgical management
The current neurosurgical management of a child with MMC 
represents one component of a multidisciplinary approach, and 
can best be divided into three phases: (i) closure of the MMC; 
(ii) treatment of the associated hydrocephalus; and (iii) long-
term surgical management.
Closure of the myelomeningocele
Initial management of the patient should follow the protocol described 
above. The closure should ideally be done within 24 hours of birth, 
but if it is delayed by more than 72 hours, the risk of the wound 
becoming colonised and infected increases substantially. Swabs of 
the wound should be taken and sent for microscopy and culture, 
and appropriate antibiotic therapy commenced where necessary. 
A history of prolonged rupture of the membranes antenatally may 
be another indication to commence antibiotic therapy. Three clean 
swabs, i.e. no organisms cultured, are required before surgical closure 
of the defect can be performed. 
Careful neurological examination of the neonate must be done 
prior to surgery so that any improvement in or worsening of the 
neurological deficit can be documented. A swab of the lesion should 
be taken in theatre, prior to closure. The surgical procedure must 
be done under general anaesthesia with adequate monitoring and 
appropriate intravenous access. The main benefit of early closure is 
prevention of infection and preservation of neurological function. 
The surgical procedure involves careful dissection of the neural 
placode, protecting any functional nerve roots. Where possible, 
the placode is then reconstituted, followed by a careful, layered, 
watertight closure of the dura and myofascial tissue. Careful repair 
of the malformation may reduce the risk of subsequent tethering. 
The skin surrounding the lesion can be quite friable and, depending 
on the complexity of the defect, related procedures can range from 
simple re-approximation through to complex reconstruction. 
Postoperative management requires meticulous care of the wound and 
dressing, also to prevent wound breakdown. These neonates should be 
nursed prone, with the nappy open to prevent faecal soiling of the wound. 
Hydrocephalus occurs in 80 - 90% of cases, caused in part by closure of 
the MMC, but mainly by the associated Chiari II malformation.[5,6] 
Daily head circumference measurements are mandatory to detect 
progressive ventricular enlargement, which can be supplemented by 
regular ultrasound examination, deferring the need for a computed 
tomography (CT) scan and the accompanying radiation. Occasionally, 
temporary CSF drainage may be required to prevent leakage from the 
MMC closure site. Apnoea monitors should be used for early detection of 
compromised respiratory function related to the Chiari II malformation.
A very important component of the management at this stage 
involves counselling of the family by a social worker, as the social 
and financial implications for the family need to be evaluated. It is 
also helpful to inform the family of the assistance available to them 
in terms of social grants, occupational therapy and special needs 
education. 
The bladder function should be evaluated by early referral to 
a urologist. Although these infants are usually incontinent, acute 
urinary retention has been described, particularly after insertion of a 
ventriculoperitoneal shunt (VPS).
Intrauterine fetal surgery for closure of an MMC has demonstrated 
some benefit as suggested in the MOMS study.[7] It appears to 
decrease the rate of shunt dependence at 1 year of age, reduces the 
risk of fetal or neonatal death, and improves the motor outcome. It 
does, however, also pose substantial risks to the mother and fetus. 
Appropriate selection criteria for and optimal timing of intrauterine 
surgery remain issues of contention. 
Treatment of hydrocephalus
Hydrocephalus may be apparent at the initial assessment or may 
become more apparent days or weeks after closure of the MMC. When 
hydrocephalus is obvious at birth, a CSF diversion procedure, usually 
an external ventricular drain (EVD), can be inserted at the time of the 
MMC closure. Some reports suggest that contemporaneous insertion 
of a VPS with MMC closure is not associated with any increased 
risk,[8] but this is not a widely accepted practice. 
Our current management protocol favours delayed VPS insertion 
once the MMC wound has completely healed – usually around 
two weeks after closure. Monitoring of hydrocephalus during this 
period can be comfortably achieved with daily head circumference 
measurements and ultrasound assessment of ventricular size. 
Ventricular taps (maximum of three taps) and EVD insertion can 
be used as temporary measures to control the hydrocephalus. VPS 
insertion is necessary in the majority of MMC patients; however, 
the malfunction rate of these shunts is high, with a third requiring 
revision within the first year. Endoscopic third ventriculostomy 
(ETV) has also been described in this setting, but has not enjoyed 
much success.[9] ETV combined with choroid plexus cautery appears 
quite promising in certain cases.[10] 
Long-term surgical management
A multidisciplinary team comprising a neurosurgeon, an orthopaedic 
surgeon, a urologist, a physiotherapist, an occupational therapist 
and a nurse co-ordinator should follow up the child with an MMC. 
This follow-up will continue throughout childhood, and often into 
adulthood. The role of the neurosurgeon largely involves monitoring 
of the hydrocephalus or checking for shunt malfunction, symptoms 
related to the Chiari II malformation, and symptoms and signs of 
spinal cord tethering. 
Conclusion
The perinatal management of children born with an MMC remains 
a challenging task, with early identification and timeous referral to 
specialist centres having a significant impact on survival. 
Table 1. Assessment of motor function
Spinal segment tested Muscle function
L2, 3 Flexion at the hip joint
L3, 4 Extension at the knee joint
L4, 5 Dorsiflexion at the ankle joint
L5, S1 Flexion at the knee joint, extension of the halux
S1, 2 Plantar flexion at the ankle joint
S2, 3 Flexion of the hallux and toes
S2, 3, 4 Anal sphincter tone or wink
Table 2. Assessment of sensory function
Spinal segment tested Dermatome
L1 Inguinal crease
L2 Femoral triangle
L3 Knee
L4 Medial leg
L5 Lateral leg and dorsum of foot
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